Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.

Cheng YQ, Ren JP, Zhao J, Wang JM, Zhou Y, Li GY, Moorman JP, Yao ZQ.

Immunology. 2015 Aug;145(4):485-97. doi: 10.1111/imm.12463. Epub 2015 Apr 21.

2.

T-bet-mediated Tim-3 expression dampens monocyte function during chronic hepatitis C virus infection.

Yi W, Zhang P, Liang Y, Zhou Y, Shen H, Fan C, Moorman JP, Yao ZQ, Jia Z, Zhang Y.

Immunology. 2017 Mar;150(3):301-311. doi: 10.1111/imm.12686. Epub 2016 Dec 7.

3.

T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.

Ju Y, Hou N, Meng J, Wang X, Zhang X, Zhao D, Liu Y, Zhu F, Zhang L, Sun W, Liang X, Gao L, Ma C.

J Hepatol. 2010 Mar;52(3):322-9. doi: 10.1016/j.jhep.2009.12.005. Epub 2010 Jan 6.

PMID:
20133006
4.

Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3.

Golden-Mason L, Waasdorp Hurtado CE, Cheng L, Rosen HR.

Clin Immunol. 2015 May;158(1):114-25. doi: 10.1016/j.clim.2015.03.008. Epub 2015 Mar 19.

PMID:
25797693
5.

Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.

Zhang Y, Ma CJ, Wang JM, Ji XJ, Wu XY, Jia ZS, Moorman JP, Yao ZQ.

PLoS One. 2011;6(5):e19664. doi: 10.1371/journal.pone.0019664. Epub 2011 May 26.

6.

The Clinical Significance of Abnormal Tim-3 Expression on NK Cells from Patients with Gastric Cancer.

Wang Z, Zhu J, Gu H, Yuan Y, Zhang B, Zhu D, Zhou J, Zhu Y, Chen W.

Immunol Invest. 2015;44(6):578-89. doi: 10.3109/08820139.2015.1052145. Epub 2015 Jul 27.

PMID:
26214042
7.

Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication.

Serti E, Werner JM, Chattergoon M, Cox AL, Lohmann V, Rehermann B.

Gastroenterology. 2014 Jul;147(1):209-220.e3. doi: 10.1053/j.gastro.2014.03.046. Epub 2014 Mar 28.

8.

KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection.

Wang JM, Cheng YQ, Shi L, Ying RS, Wu XY, Li GY, Moorman JP, Yao ZQ.

J Virol. 2013 Nov;87(21):11626-36. doi: 10.1128/JVI.01515-13. Epub 2013 Aug 21.

9.

Natural killer cells inhibit hepatitis C virus expression.

Li Y, Zhang T, Ho C, Orange JS, Douglas SD, Ho WZ.

J Leukoc Biol. 2004 Dec;76(6):1171-9. Epub 2004 Aug 31.

PMID:
15339939
10.

Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.

McMahan RH, Golden-Mason L, Nishimura MI, McMahon BJ, Kemper M, Allen TM, Gretch DR, Rosen HR.

J Clin Invest. 2010 Dec;120(12):4546-57. doi: 10.1172/JCI43127. Epub 2010 Nov 15. Erratum in: J Clin Invest. 2011 Feb 1;121(2):821.

11.

Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection.

Wang JM, Ma CJ, Li GY, Wu XY, Thayer P, Greer P, Smith AM, High KP, Moorman JP, Yao ZQ.

Vaccine. 2013 Apr 26;31(18):2238-45. doi: 10.1016/j.vaccine.2013.03.003. Epub 2013 Mar 14.

12.

Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.

Yoon JC, Lim JB, Park JH, Lee JM.

J Virol. 2011 Dec;85(23):12557-69. doi: 10.1128/JVI.00838-11. Epub 2011 Sep 21.

13.

Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.

Gleason MK, Lenvik TR, McCullar V, Felices M, O'Brien MS, Cooley SA, Verneris MR, Cichocki F, Holman CJ, Panoskaltsis-Mortari A, Niki T, Hirashima M, Blazar BR, Miller JS.

Blood. 2012 Mar 29;119(13):3064-72. doi: 10.1182/blood-2011-06-360321. Epub 2012 Feb 8.

14.

Differential regulation of interleukin-12 (IL-12)/IL-23 by Tim-3 drives T(H)17 cell development during hepatitis C virus infection.

Wang JM, Shi L, Ma CJ, Ji XJ, Ying RS, Wu XY, Wang KS, Li G, Moorman JP, Yao ZQ.

J Virol. 2013 Apr;87(8):4372-83. doi: 10.1128/JVI.03376-12. Epub 2013 Feb 6.

15.

Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.

Ndhlovu LC, Lopez-Vergès S, Barbour JD, Jones RB, Jha AR, Long BR, Schoeffler EC, Fujita T, Nixon DF, Lanier LL.

Blood. 2012 Apr 19;119(16):3734-43. doi: 10.1182/blood-2011-11-392951. Epub 2012 Mar 1.

16.

Immunological changes in different patient populations with chronic hepatitis C virus infection.

Szereday L, Meggyes M, Halasz M, Szekeres-Bartho J, Par A, Par G.

World J Gastroenterol. 2016 May 28;22(20):4848-59. doi: 10.3748/wjg.v22.i20.4848.

17.

Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection.

Miyagi T, Takehara T, Nishio K, Shimizu S, Kohga K, Li W, Tatsumi T, Hiramatsu N, Kanto T, Hayashi N.

J Hepatol. 2010 Sep;53(3):424-30. doi: 10.1016/j.jhep.2010.03.018. Epub 2010 May 25.

PMID:
20554341
18.

Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101.

Stelma F, van der Ree MH, Sinnige MJ, Brown A, Swadling L, de Vree JML, Willemse SB, van der Valk M, Grint P, Neben S, Klenerman P, Barnes E, Kootstra NA, Reesink HW.

Hepatology. 2017 Jul;66(1):57-68. doi: 10.1002/hep.29148. Epub 2017 Jun 7.

19.

Regulation of Human Natural Killer Cell IFN-γ Production by MicroRNA-146a via Targeting the NF-κB Signaling Pathway.

Wang H, Zhang Y, Wu X, Wang Y, Cui H, Li X, Zhang J, Tun N, Peng Y, Yu J.

Front Immunol. 2018 Mar 9;9:293. doi: 10.3389/fimmu.2018.00293. eCollection 2018.

20.

Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.

Golden-Mason L, Madrigal-Estebas L, McGrath E, Conroy MJ, Ryan EJ, Hegarty JE, O'Farrelly C, Doherty DG.

Gut. 2008 Aug;57(8):1121-8. doi: 10.1136/gut.2007.130963. Epub 2008 Mar 27.

PMID:
18372499

Supplemental Content

Support Center